Alpha 2.0
Login Register
» Articles » PMID: 31812188

POINT: Should Initial Combination Therapy Be the Standard of Care in Pulmonary Arterial Hypertension? Yes

Overview
Journal Chest
Publisher Elsevier
Specialty Pulmonary Medicine
Date 2019 Dec 9
PMID 31812188
Citations 4
Authors
Marc Humbert
Edmund M T Lau
Affiliations
Soon will be listed here.
Citing Articles

Contribution of pressure and flow changes to resistance reduction after pulmonary arterial hypertension treatment: a meta-analysis of 3898 patients.

Farmakis I, Baroutidou A, Patsiou V, Arvanitaki A, Doundoulakis I, Hobohm L ERJ Open Res. 2024; 10(1).

PMID: 38259812 PMC: 10801731. DOI: 10.1183/23120541.00706-2023.

Pulmonary vascular disease as a complication of pediatric congenital heart diseases.

Wacker J, Joye R, Genecand L, Lador F, Beghetti M Transl Pediatr. 2023; 12(5):1041-1052.

PMID: 37305723 PMC: 10248925. DOI: 10.21037/tp-23-64.

Relevance of comorbidities on initial combination therapy in pulmonary arterial hypertension.

Badagliacca R, DAlto M, Ghio S, Argiento P, Brunetti N, Casu G ERJ Open Res. 2022; 8(4).

PMID: 36382240 PMC: 9638831. DOI: 10.1183/23120541.00298-2022.

Haemodynamic effects of initial combination therapy in pulmonary arterial hypertension: a systematic review and meta-analysis.

Farmakis I, Vrana E, Mouratoglou S, Zafeiropoulos S, Zanos S, Giannakoulas G ERJ Open Res. 2022; 8(4).

PMID: 36299361 PMC: 9589336. DOI: 10.1183/23120541.00313-2022.